Burns JC - Search Results

1

Epidemiological and Clinical Features of Kawasaki Disease During the COVID-19 Pandemic in the United States.

Burney JA, Roberts SC, DeHaan LL, Shimizu C, Bainto EV, Newburger JW, Dominguez S, Jone PN, Jaggi P, Szmuszkovicz JR, Rowley AH, Samuy N, Scalici P, Tremoulet AH, Cayan DR, Burns JC; KIDCARE Study Investigators. Burney JA, et al. Among authors: burns jc. JAMA Netw Open. 2022 Jun 1;5(6):e2217436. doi: 10.1001/jamanetworkopen.2022.17436. JAMA Netw Open. 2022. PMID: 35713905 Free PMC article.

2

Erythrocyte sedimentation rate and C-reactive protein discrepancy and high prevalence of coronary artery abnormalities in Kawasaki disease.

Anderson MS, Burns J, Treadwell TA, Pietra BA, Glodé MP. Anderson MS, et al. Pediatr Infect Dis J. 2001 Jul;20(7):698-702. doi: 10.1097/00006454-200107000-00011. Pediatr Infect Dis J. 2001. PMID: 11465843

3

Recurrent Kawasaki disease-like syndrome in a patient with acquired immunodeficiency syndrome.

Blanchard JN, Powell HC, Freeman WR, Letendre S, Blanchard D, Shimizu C, Burns JC. Blanchard JN, et al. Among authors: burns jc. Clin Infect Dis. 2003 Jan 1;36(1):105-11. doi: 10.1086/345465. Epub 2002 Dec 13. Clin Infect Dis. 2003. PMID: 12491210

4

Organization and expression analysis of the zebrafish hepcidin gene, an antimicrobial peptide gene conserved among vertebrates.

Shike H, Shimizu C, Lauth X, Burns JC. Shike H, et al. Among authors: burns jc. Dev Comp Immunol. 2004 Jun;28(7-8):747-54. doi: 10.1016/j.dci.2003.11.009. Dev Comp Immunol. 2004. PMID: 15043943

5

Failure to diagnose Kawasaki disease at the extremes of the pediatric age range.

Pannaraj PS, Turner CL, Bastian JF, Burns JC. Pannaraj PS, et al. Among authors: burns jc. Pediatr Infect Dis J. 2004 Aug;23(8):789-91. doi: 10.1097/01.inf.0000134312.39744.a4. Pediatr Infect Dis J. 2004. PMID: 15295237

6

Kawasaki syndrome.

Burns JC, Glodé MP. Burns JC, et al. Lancet. 2004 Aug 7-13;364(9433):533-44. doi: 10.1016/S0140-6736(04)16814-1. Lancet. 2004. PMID: 15302199 Review.

7

Quantitation of adenovirus genome during acute infection in normal children.

Shike H, Shimizu C, Kanegaye J, Foley JL, Burns JC. Shike H, et al. Among authors: burns jc. Pediatr Infect Dis J. 2005 Jan;24(1):29-33. doi: 10.1097/01.inf.0000148882.97399.79. Pediatr Infect Dis J. 2005. PMID: 15665707 Free PMC article.

8

Seasonality and temporal clustering of Kawasaki syndrome.

Burns JC, Cayan DR, Tong G, Bainto EV, Turner CL, Shike H, Kawasaki T, Nakamura Y, Yashiro M, Yanagawa H. Burns JC, et al. Epidemiology. 2005 Mar;16(2):220-5. doi: 10.1097/01.ede.0000152901.06689.d4. Epidemiology. 2005. PMID: 15703537 Free PMC article.

9

Infliximab treatment for refractory Kawasaki syndrome.

Burns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD, Balfour I, Shen CA, Michel ED, Shulman ST, Melish ME. Burns JC, et al. J Pediatr. 2005 May;146(5):662-7. doi: 10.1016/j.jpeds.2004.12.022. J Pediatr. 2005. PMID: 15870671

10

Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease.

Burns JC, Shimizu C, Gonzalez E, Kulkarni H, Patel S, Shike H, Sundel RS, Newburger JW, Ahuja SK. Burns JC, et al. J Infect Dis. 2005 Jul 15;192(2):344-9. doi: 10.1086/430953. Epub 2005 Jun 8. J Infect Dis. 2005. PMID: 15962231 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

463 results

Search Page